Florencia G. Jalikis

Author

Also Known As

F. G. Jalikis, F. Jalikis, F.G. Jalikis, Florencia G Jalikis, Florencia G. Jalikis, Florencia Jalikis, Lisa Koch, Marcus Tan

Publications

910

Citations

H-Index

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center University of Washington Medical Center Stanford University Vanderbilt University

About

Florencia G. Jalikis is an author at University of Washington specializing in medicine, pathology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	216
2	Engineering	1	1	33
3	Health Sciences	1	1	32
4	Biomedical Engineering	1	1	33
5	Cell Biology	1	1	33

Florencia G. Jalikis

Publications

806

Citations

H-Index

Page 1

	Year	Citations
Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer Yongwoo David Seo, Xiuyun Jiang, Kevin M. Sullivan, Clinical Cancer Research	2019	216
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues Ashwini Balakrishnan, Tracy Goodpaster, Julie Randolph‐Habecker, Clinical Cancer Research	2016	204
‘Non-classical’ HER2 FISH results in breast cancer: a multi-institutional study Morgan Ballard, Florencia G. Jalikis, Gregor Krings, Modern Pathology Breast OncologyMedicinePathologyCancer PreventionBreast Cancer	2016	99
Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment Xiuyun Jiang, Yongwoo David Seo, Jae Hyuck Chang, OncoImmunology	2017	80
Copper Deficiency in Liver Diseases: A Case Series and Pathophysiological Considerations Lei Yu, Iris Liou, Scott W. Biggins, Hepatology Communications	2019	39
Validation of a Congestive Hepatic Fibrosis Scoring System Dustin E. Bosch, Konstantin Koro, Elizabeth Richards, The American Journal of Surgical Pathology FibrosisHeart FailureHepatologyCongestive HepatopathyLiver Physiology	2019	36
Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis Richard D. Kenagy, Nozomi Fukai, Seung-Kee Min, Journal of Vascular Surgery Regenerative MedicineVascular Tissue EngineeringEngineeringGraft StenosisVascular Biology	2009	33
Randomized phase II study of second-line modified FOLFIRI with PARP inhibitor ABT-888 (Veliparib) (NSC-737664) versus FOLFIRI in metastatic pancreatic cancer (mPC): SWOG S1513. E. Gabriela Chiorean, Katherine A. Guthrie, Philip Agop Philip, Journal of Clinical Oncology Line Mpc PatientsImmunologyPathologyPharmacotherapyTumor Biology	2019	32
High prevalence of <i>Helicobacter pylori</i> clarithromycin resistance mutations among Seattle patients measured by droplet digital <scp>PCR</scp> Sarah Talarico, Andrew S. Korson, Christina K. Leverich, Helicobacter	2018	29
Acute Liver Failure Due to Echovirus 9 Associated With Persistent B-Cell Depletion From Rituximab Kristina L. Bajema, Paul D. Simonson, Alexander L. Greninger, Open Forum Infectious Diseases ImmunologyHepatitis BPathologyImmunotherapyViral Persistence	2017	16

Page 1